Dr. Salvador Plasencia, a physician implicated in the death of actor Matthew Perry, has entered a guilty plea to four counts of ketamine distribution. This development comes as part of an ongoing investigation into the circumstances surrounding Perry’s untimely demise in October 2023.
Dr. Plasencia’s admission of guilt marks him as the fourth individual to be convicted in connection with Perry’s overdose. According to reliable sources within the Department of Justice, the doctor has expressed remorse for his treatment decisions and intends to surrender his medical license within the next 30 to 45 days.
Matthew Perry, best known for his role in the television series “Friends,” was found unresponsive in his Los Angeles home on October 28, 2023. An autopsy subsequently revealed that the 54-year-old actor succumbed to the acute effects of ketamine, a powerful anesthetic.
Dr. Plasencia distributed ketamine to Perry and his live-in assistant, Kenneth Iwamasa, in the weeks leading up to the actor’s death. Court documents suggest that the doctor’s conduct fell below the proper standard of medical care, with transfers of ketamine not being for legitimate medical purposes.
Other individuals have also been charged in this case. Dr. Mark Chavez, another physician, has already pleaded guilty to distributing ketamine. Mr. Iwamasa and Eric Fleming have admitted to their roles in supplying the drug to Perry. A fifth defendant, Jasveen Sangha, has pleaded not guilty and awaits trial.
This case raises important questions about medical ethics, the regulation of at-home ketamine treatments, and the vulnerability of individuals struggling with addiction. As the legal proceedings continue, the medical community and regulatory bodies may face increased scrutiny over their oversight of controlled substances.
Dr. Plasencia is scheduled for sentencing on December 3rd. The evidence suggests he could face up to 10 years in federal prison for each count. As this story continues to unfold, we will provide updates on the outcomes of the remaining trials and any policy changes that may result from this tragic event.
